Onkologie. 2020:14(4):142-147 | DOI: 10.36290/xon.2020.056

Epidemiology of breast neoplasms at the time of organized screening program in the Czech Republic

Lucie Pehalová1, Denisa Krejčí1,2, Ivana Svobodová1,2, Ondřej Ngo1,2, Ondřej Májek1,2, Jan Mužík1,2, Ladislav Dušek1,2
1 Ústav zdravotnických informací a statistiky České republiky, Praha
2 Institut biostatistiky a analýz, Lékařská fakulta, Masarykova univerzita, Brno

Malignant breast neoplasms are the most common cancer in women apart from non-melanoma skin cancer and thus represent a significant health burden on the Czech population. The aim of this study was to comprehensively describe the epidemiological situation of breast neoplasms in the Czech Republic with respect to the impact of organized mammary screening. The results of our analysis revealed that the greatest impact of organized screening is evident for the 45-69 age group. After the implementation of organized screening, incidence in this age group has stabilized and a significant decrease in mortality of 3.2 % each year was recorded (p < 0.001). In contrast, a significant increase of 6.8 % per year (p < 0.001) was observed for incidence of neoplasms in situ. In this age group, there was also a higher proportion of early clinical stages among newly diagnosed neoplasms in the post-screening period. Obtained results show, that after the implementation of organized mammary screening there is a positive trend of epidemiological characteristics of breast neoplasms in the Czech Republic.

Keywords: cancer epidemiology, malignant breast neoplasm, breast neoplasm in situ, organized screening program, National Cancer Registry.

Published: September 23, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pehalová L, Krejčí D, Svobodová I, Ngo O, Májek O, Mužík J, Dušek L. Epidemiology of breast neoplasms at the time of organized screening program in the Czech Republic. Onkologie. 2020;14(4):142-147. doi: 10.36290/xon.2020.056.
Download citation

References

  1. Ústav zdravotnických informací a statistiky ČR. Národní zdravotnický informační systém (NZIS), Národní onkologický registr (NOR) [online]. [cit. 20. 3. 2020]. Dostupné z: http://www.uzis.cz/registry-nzis/nor.
  2. Dušek L, Mužík J, Kubásek M, et al. Epidemiologie zhoubných nádorů v České republice [online]. Masarykova univerzita, Brno, 2005. [cit. 18. 5. 2020]. Dostupné z: http://www.svod.cz.
  3. Majek O, Danes J, Skovajsova M, et al. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC public health, 2011: 11(1/288). Go to original source...
  4. Český statistický úřad. Demografická příručka 2017 [online]. [cit. 20. 3. 2020]. Dostupné z: https://www.czso.cz/csu/czso/demograficka-prirucka-2017.
  5. Ústav zdravotnických informací a statistiky ČR. Národní zdravotnický informační systém (NZIS), List o prohlídce zemřelého (LPZ), [cit. 20. 3. 2020]. Dostupné z: http://www.uzis.cz/registry-nzis/list-prohlidce-zemreleho.
  6. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today [online]. Lyon, France: International Agency for Research on Cancer, 2018. [cit. 23. 3. 2020]. Dostupné z: https://gco.iarc.fr/today.
  7. Mamo.cz - Program mamografického screeningu v České republice [online]. Masarykova univerzita, Brno, 2019. [cit. 18. 5. 2020]. Dostupné z: https://www.mamo.cz.
  8. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000; 19(1): 335-351. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.